Group A Strep: the bacteria behind strep throat, study by study
Last reviewed November 15, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
Strep throat is caused by Streptococcus pyogenes, a round bacterium that grows in chains. Doctors call it Group A Strep, or GAS. It lives only in people and spreads through coughs, sneezes, and close contact.
Most of the time it causes strep throat or skin infections like impetigo. Rarely it causes dangerous illnesses, and weeks after an infection it can trigger rheumatic fever, which can damage the heart. Below are the key studies about this germ, in order.
Related pages: Strep throat · Scarlet fever · Rheumatic fever · Impetigo · Toxic shock syndrome
The bottom line
- Group A Strep causes strep throat, scarlet fever, and impetigo, and sometimes severe infections.
- Treating strep throat with antibiotics like penicillin helps prevent rheumatic fever.
- Worldwide it causes hundreds of millions of sore throats and about half a million deaths a year, mostly from rheumatic heart disease.
- Why some strains suddenly spread and cause more severe illness.
- Exactly how a strep infection leads to rheumatic fever. The leading idea is mistaken identity: the immune response to strep also attacks the heart.
- Whether a vaccine will work. There's no approved vaccine yet. The first human studies began in 2025 and 2026.
The studies, in order
- 1. Sorting the strep family (Rebecca Lancefield, 1933)
- 2. Penicillin and the heart (Denny, Wannamaker, Rammelkamp, and others, 1950)
- 3. How big is it (Carapetis, Steer, Mulholland, and Weber, 2005)
- 4. How a strain turns dangerous (Nasser, Musser, and others, 2014)
- 5. A new strain in England (Lynskey, Sriskandan, and others, 2019)
- 6. Vaccines being tested (GSK (from 2025) and Vaxcyte (from 2026))
What the evidence labels mean
Rebecca Lancefield divides streptococci into groups
What they did
Lancefield, at the Rockefeller Institute in New York, tested 106 streptococcus strains from people, animals, milk, and cheese, using antibodies against sugars on the surface of the bacteria.
What they found
- All but 2 strains fell into 5 groups, and the groups matched where the germs came from.
- The marker for the group found in people, Group A, was a carbohydrate (a sugar) on the cell wall.
- The strains that cause illness in people fell into Group A.
What it means
Labs could finally tell the strep that matters in people apart from its many relatives. 'Group A Strep' is still the name used today.
What it can't tell us
- Grouping by a surface sugar is a lab shortcut. Later DNA studies reorganized some groups.
Read it yourself
- Lancefield 1933 (PubMed)PubMed
- Lancefield 1933, full textJournal
Next: Penicillin and the heart
Treating strep throat prevents rheumatic fever
What they did
Young airmen with strep throat were given penicillin or no specific treatment, with groups assigned by the last digit of their Air Force serial number, then followed to see who developed rheumatic fever.
What they found
- Rheumatic fever was much less common in the airmen treated with penicillin.
- In this study and a follow-up, 978 treated men were compared with 996 untreated men.
- The work also gave strong evidence that strep is what leads to rheumatic fever.
What it means
This is why doctors still test for and treat strep throat even though it often gets better on its own: the antibiotic protects the heart.
What it can't tell us
- Assigning treatment by serial number isn't fully random, though it came close.
- It studied young men in the military. Later studies confirmed the benefit in children.
Read it yourself
Next: How big is it
Over 600 million sore throats a year worldwide
What they did
The team pulled together population studies from around the world to estimate how much illness Group A Strep causes.
What they found
- At least 517,000 deaths each year from severe strep-related disease.
- The biggest cause of those deaths is rheumatic heart disease: at least 15.6 million people living with it and 233,000 deaths a year.
- Over 616 million new cases of strep sore throat a year, and over 111 million people with strep skin infections at any one time.
What it means
Strep throat is usually mild for one person, but worldwide this germ is a major cause of death, mostly in poorer countries where rheumatic fever is still common.
What it can't tell us
- Data from many lower-income countries were poor, so these are estimates and are probably too low.
Read it yourself
- Carapetis 2005 (PubMed)PubMed
Changes in one bacterial cell led to a worldwide strain
What they did
Researchers read the full DNA of 3,615 samples of one common strep type, called M1, collected in many countries, to trace how an unusually harmful version arose.
What they found
- The strain built up step by step, picking up toxin genes carried by phages, which are viruses that infect bacteria.
- Its last big change, gaining a stretch of DNA with more toxin genes, happened in a single cell in the early 1980s.
- That strain then spread across continents, and in animal tests it was more harmful than an older strain.
What it means
Strep can swap toxin genes, and a few changes in one bacterium can end up causing millions of infections.
What it can't tell us
- This looked at one strep type. Others may change in different ways.
Read it yourself
Next: A new strain in England
The M1UK strain makes about 9 times more scarlet fever toxin
What they did
After England saw its biggest rise in scarlet fever in modern times starting in 2014, researchers studied strep samples from 2009 to 2016 and compared them with 2,800 samples from around the world.
What they found
- A new version of the M1 strain, called M1UK, had appeared.
- It made about 9 times more of the scarlet fever toxin (SpeA) than the older global strain.
- By 2016 it made up 84% of M1 strep samples in England, and single samples had also turned up in Denmark and the US.
What it means
A strain that spreads well and makes more toxin may explain the jump in scarlet fever and severe strep infections, and shows why health agencies track strains.
What it can't tell us
- The study links the new strain to the rise in cases, but other things may also play a part.
Read it yourself
Next: Vaccines being tested
The first new strep vaccines reach people
What they did
After decades of setbacks, two companies began testing strep vaccines in healthy adults to check safety and the immune response.
What they found
- GSK began a 108-person study in July 2025 of a vaccine made from 4 strep parts, given as 3 shots to adults aged 18 to 25 in Australia.
- Vaxcyte gave the first dose of its vaccine, VAX-A1, in June 2026, in a study of about 80 adults aged 18 to 40, also in Australia.
- No results are out yet. Vaxcyte expects its first results in the second half of 2027.
What it means
A vaccine could prevent strep throat and rheumatic heart disease, and cut down on antibiotic use.
What it can't tell us
- Phase 1 trials only check safety and the immune response. It will take years to learn whether a vaccine prevents illness.
- Strep comes in many types, which has made vaccines hard to design.
Read it yourself
- GSK Strep A vaccine trial recordClinicalTrials.gov
- Vaxcyte VAX-A1 trial recordClinicalTrials.gov
- Vaxcyte announcement, June 2026Company